UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Near-infrared imaging in a microfluidic channel of aqueous acid–base reactions

Chemical engineering journal (Lausanne, Switzerland : 1996), 2021-01, Vol.403, p.126338, Article 126338

2021

Volltextzugriff (PDF)

Determination of salt production rates and diffusion coefficient in acid-base reactions using near-infrared absorption images

The Proceedings of Conference of Kanto Branch, 2021, Vol.2021.27, p.11

2021

Volltextzugriff (PDF)

Principal component analysis for the near-infrared spectroscopic imaging

The Proceedings of Conference of Kanto Branch, 2020-03, Vol.2020, p.17

2020

Volltextzugriff (PDF)

Optimization of multi-linear regression model for neutralization reaction analysis using near-infrared spectroscopic imaging

The Proceedings of Mechanical Engineering Congress, Japan, 2020, Vol.2020, p.J05223

2020

Volltextzugriff (PDF)

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Potent and Selective Human β3-Adrenergic Receptor Agonists with Good Oral Bioavailability. Part I

Journal of medicinal chemistry, 2008-03, Vol.51 (6), p.1925-1944

2008

Volltextzugriff (PDF)

Discovery of highly potent and selective biphenylacylsulfonamide-based β3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the β2-adrenergic receptor: Part 6

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (16), p.4679-4683

2009

Volltextzugriff (PDF)

Discovery of Highly Potent and Selective Biphenylacylsulfonamide-Based β3-Adrenergic Receptor Agonists and Evaluation of Physical Properties as Potential Overactive Bladder Therapies: Part 5

Journal of medicinal chemistry, 2009-05, Vol.52 (9), p.3063-3072

2009

Volltextzugriff (PDF)

Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human β3-adrenergic receptor agonists: Part IV

Bioorganic & medicinal chemistry letters, 2008-09, Vol.18 (18), p.5037-5040

2008

Volltextzugriff (PDF)

Discovery of a Novel Series of Benzoic Acid Derivatives as Potent and Selective Human β3 Adrenergic Receptor Agonists with Good Oral Bioavailability. 3. Phenylethanolaminotetraline (PEAT) Skeleton Containing Biphenyl or Biphenyl Ether Moiety

Journal of medicinal chemistry, 2008-08, Vol.51 (15), p.4804-4822

2008

Volltextzugriff (PDF)

Discovery of a novel, potent and selective human β 3-adrenergic receptor agonist

Bioorganic & medicinal chemistry letters, 2005-01, Vol.15 (2), p.251-254

2005

Volltextzugriff (PDF)

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Highly Potent and Selective Human β3 Adrenergic Receptor Agonists with Good Oral Bioavailability. Part II

Journal of medicinal chemistry, 2008-07, Vol.51 (13), p.4002-4020

2008

Volltextzugriff (PDF)

Potential Candidates for Cardiac Resynchronization Therapy in Japanese Patients With Idiopathic Dilated Cardiomyopathy: A Niigata Multicenter Study of DCM

Circulation Journal, 2004, Vol.68(12), pp.1104-1109

2004

Volltextzugriff (PDF)

Characterization and Subcellular Localization of KCNQ1 with a Heterozygous Mutation in the C Terminus

Journal of molecular and cellular cardiology, 2001-02, Vol.33 (2), p.197-207

2001

Volltextzugriff (PDF)

Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta(3)-adrenergic receptor agonists: Part IV

Bioorganic & medicinal chemistry letters, 2008-09, Vol.18 (18), p.5037-5040

2008

Volltextzugriff (PDF)

Discovery of a Novel Series of Benzoic Acid Derivatives as Potent and Selective Human β 3 Adrenergic Receptor Agonists with Good Oral Bioavailability. 3. Phenylethanolaminotetraline (PEAT) Skeleton Containing Biphenyl or Biphenyl Ether Moiety

Journal of medicinal chemistry, 2008-08, Vol.51 (15), p.4804-4822

2008

Volltextzugriff (PDF)

Discovery of Highly Potent and Selective Biphenylacylsulfonamide-Based β 3 -Adrenergic Receptor Agonists and Evaluation of Physical Properties as Potential Overactive Bladder Therapies: Part 5

Journal of medicinal chemistry, 2009-05, Vol.52 (9), p.3063-3072

2009

Volltextzugriff (PDF)

Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part I

Journal of medicinal chemistry, 2008-03, Vol.51 (6), p.1925-1944

2008

Volltextzugriff (PDF)

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Potent and Selective Human β 3 -Adrenergic Receptor Agonists with Good Oral Bioavailability. Part I

Journal of medicinal chemistry, 2008-03, Vol.51 (6), p.1925-1944

2008

Volltextzugriff (PDF)

Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta sub(3)-adrenergic receptor agonists: Part IV

Bioorganic & medicinal chemistry, 2008-09, Vol.18 (18), p.5037-5040

2008

Volltextzugriff (PDF)

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Highly Potent and Selective Human fi3 Adrenergic Receptor Agonists with Good Oral Bioavailability. Part II

Journal of medicinal chemistry, 2008, Vol.51 (13), p.4002-4020

2008

Volltextzugriff (PDF)

Discovery of highly potent and selective biphenylacylsulfonamide-based beta sub(3)-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the beta sub(2)-adrenergic receptor: Part 6

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (16), p.4679-4683

2009

Volltextzugriff (PDF)

Discovery of highly potent and selective biphenylacylsulfonamide-based β 3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the β 2-adrenergic receptor: Part 6

Bioorganic & medicinal chemistry letters, 2009, Vol.19 (16), p.4679-4683

2009

Volltextzugriff (PDF)

Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human β 3-adrenergic receptor agonists: Part IV

Bioorganic & medicinal chemistry letters, 2008, Vol.18 (18), p.5037-5040

2008

Volltextzugriff (PDF)

Discovery of a novel, potent and selective human beta3-adrenergic receptor agonist

Bioorganic & medicinal chemistry letters, 2005-01, Vol.15 (2), p.251-254

2005

Volltextzugriff (PDF)

Discovery of a novel, potent and selective human β3-adrenergic receptor agonist

Bioorganic & medicinal chemistry letters, 2005, Vol.15 (2), p.251-254

2005

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(38)

Sprache

Englisch
(37)
Japanisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Near-infrared imaging in a microfluidic channel of aqueous acid–base reactions

Determination of salt production rates and diffusion coefficient in acid-base reactions using near-infrared absorption images

Principal component analysis for the near-infrared spectroscopic imaging

Optimization of multi-linear regression model for neutralization reaction analysis using near-infrared spectroscopic imaging

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Potent and Selective Human β3-Adrenergic Receptor Agonists with Good Oral Bioavailability. Part I

Discovery of highly potent and selective biphenylacylsulfonamide-based β3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the β2-adrenergic receptor: Part 6

Discovery of Highly Potent and Selective Biphenylacylsulfonamide-Based β3-Adrenergic Receptor Agonists and Evaluation of Physical Properties as Potential Overactive Bladder Therapies: Part 5

Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human β3-adrenergic receptor agonists: Part IV

Discovery of a Novel Series of Benzoic Acid Derivatives as Potent and Selective Human β3 Adrenergic Receptor Agonists with Good Oral Bioavailability. 3. Phenylethanolaminotetraline (PEAT) Skeleton Containing Biphenyl or Biphenyl Ether Moiety

Discovery of a novel, potent and selective human β 3-adrenergic receptor agonist

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Highly Potent and Selective Human β3 Adrenergic Receptor Agonists with Good Oral Bioavailability. Part II

Potential Candidates for Cardiac Resynchronization Therapy in Japanese Patients With Idiopathic Dilated Cardiomyopathy: A Niigata Multicenter Study of DCM

Characterization and Subcellular Localization of KCNQ1 with a Heterozygous Mutation in the C Terminus

Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta(3)-adrenergic receptor agonists: Part IV

Discovery of a Novel Series of Benzoic Acid Derivatives as Potent and Selective Human β 3 Adrenergic Receptor Agonists with Good Oral Bioavailability. 3. Phenylethanolaminotetraline (PEAT) Skeleton Containing Biphenyl or Biphenyl Ether Moiety

Discovery of Highly Potent and Selective Biphenylacylsulfonamide-Based β 3 -Adrenergic Receptor Agonists and Evaluation of Physical Properties as Potential Overactive Bladder Therapies: Part 5

Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part I

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Potent and Selective Human β 3 -Adrenergic Receptor Agonists with Good Oral Bioavailability. Part I

Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta sub(3)-adrenergic receptor agonists: Part IV

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Highly Potent and Selective Human fi3 Adrenergic Receptor Agonists with Good Oral Bioavailability. Part II

Discovery of highly potent and selective biphenylacylsulfonamide-based beta sub(3)-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the beta sub(2)-adrenergic receptor: Part 6

Discovery of highly potent and selective biphenylacylsulfonamide-based β 3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the β 2-adrenergic receptor: Part 6

Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human β 3-adrenergic receptor agonists: Part IV

Discovery of a novel, potent and selective human beta3-adrenergic receptor agonist

Discovery of a novel, potent and selective human β3-adrenergic receptor agonist

Suchergebnisse filtern